Company Presentations /
by -
4 years ago
23 Apr 2020 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer, Dr. David Cade talks about the company's product pipeline, financials and strategy.
Interviews /
by Rachael Jones -
4 years ago
24 Apr 2020 - Telix Pharmaceuticals (ASX:TLX), Chief Business Officer, David Cade talks about its prostate cancer imaging product, diagnostic and therapeutic products, partners and…
Market Reports /
by Rachael Jones -
4 years ago
23 Jan 2020 - It has been a negative day of trade for the ASX closing 0.6% lower. Shares shot up for National Storage REIT (ASX:NSR) after they confirmed they had received a takeov…
Market Reports /
by Rachael Jones -
4 years ago
27 Dec 2019 - The ASX unfortunately is looking to take a dip after its break although Wall Street saw some movement in the opposite direction rising up in overnight trade. Wall Str…
Market Reports /
by Rachael Jones -
4 years ago
23 Dec 2019 - The ASX took a dip at the open and has continued to fall throughout the morning now tracking 0.3% lower at noon. Jumbo (ASX:JIN) shares have fallen as have NearMap (A…
Company News /
by Katrina Bullock -
4 years ago
20 Dec 2019 - Biopharmaceutical company, Telix Pharmaceuticals (ASX:TLX) is pleased to announce that Telix collaborator Professor Frédéric Hollande has been awarded a research gran…
Company News /
by Rachael Jones -
5 years ago
07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of In…
Company News /
by Rachael Jones -
5 years ago
03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with technology giant Eckert & Ziegler to acquire a radiopharmaceutical production f…
Interviews /
by Anna Napoli -
5 years ago
30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefits of using its diagnostic and therap…
Company Presentations /
by -
5 years ago
30 May 2019 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch discusses the company’s development pipeline and the benefit of diagnostic and therapeutic produ…
Company News /
by Katrina Bullock -
5 years ago
26 Apr 2019 - Telix Pharmaceuticals (ASX:TLX) has announced that phase two of its prostate drug clinical data demonstrates that low, repeated doses significantly reduce hematologic…
Market Reports /
by Rachael Jones -
5 years ago
24 Jan 2019 - The ASX opened higher and is now tracking 0.2% higher at noon. Santos (ASX:STO) stock is one of the best performers today after announcing their record quarterly sale…
Market Reports /
by Anna Napoli -
5 years ago
08 Jan 2019 - Australian shares are expected to edge higher this morning following a rally on Wall Street. Biotech company, Telix Pharmaceuticals (ASX:TLX) has announced the accele…
Company News /
by Rachael Jones -
6 years ago
10 Oct 2018 - Biopharmaceutical company Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement with GenesisCare, the largest private provider of oncol…
Company News /
by Anna Napoli -
6 years ago
11 Sep 2018 - Telix Pharmaceuticals (ASX:TLX) has today announced the completion of its acquisition of Atlab Pharma.
Company News /
by Anna Napoli -
6 years ago
04 Sep 2018 - Biopharmaceutical company, Telix (ASX:TLX) has secured ethics approval to commence a Phase1/11 study for the use of its drug to treat recurrent glioblastoma.
Market Reports /
by Rachael Jones -
6 years ago
30 May 2018 - Australian shares closed lower today - 29 per cent lower. That's the market's lowest close since April 30. Rio (ASX:RIO) is continuing its slide from yesterday, BHP (…
Company Presentations /
by -
6 years ago
02 May 2018 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch, presents the company’s development of diagnostic and therapeutic products based on molecularly …
Interviews /
by Rachael Jones -
6 years ago
02 May 2018 - Telix Pharmaceuticals Limited (ASX:TLX) CEO, Dr Christian Behrenbruch, discusses the company’s development of diagnostic and therapeutic products based on molecularly…
Company News /
by Anna Napoli -
6 years ago
10 Apr 2018 - Pharmaceutical company, Telix Pharmaceuticals (ASX:TLX) has signed a contract with US biotech company Endocyte.
Market Reports /
by Rachael Jones -
6 years ago
26 Mar 2018 - The Australian share market opened lower this morning in response to heavy declines in the US but stablised throughout the day. Administrators have been called in to …
Market Reports /
by Clive Tompkins -
7 years ago
15 Nov 2017 - Market retreats after three-session high: Aus shares close 0.15% lower. Clean Seas Seafood (ASX:CSS) has successfully completed a $17.6 million capital raise. The fun…
Market Reports /
by Kathy Skantzos -
7 years ago
15 Nov 2017 - ASX dropped after a weak start from Wall Street. The drop in the iron ore price put a cap on gains. Health care and technology are performing well while the other sec…
